Lilly $1.8 billion investment to bolster Irish manufacturing
The expansion is planned to enhance Eli Lilly's medicine production and both sites are set to harness advanced sustainability capabilities.
Innovative medicine production site inaugurated in France
Sanofi’s novel manufacturing unit in France enables rapid changes in production capacities for medicines such as biologics and vaccines.
GSK ultra-long-acting biologic shows Phase III potential
The treatment, being evaluated for severe asthma, is the first ultra-long-acting biologic to be evaluated in Phase III trials.
Driving economic growth in UK with commercial clinical trials
The research “clearly demonstrates" the benefits industry clinical trials have on the UK economy, says APBI Chief Exec about the report.
Patient insights into the decentralisation of clinical trials
While a trial is a part of pharma research, despite industry advancement, the patient experience is not often considered for innovation.
Monocyte activation test (MAT): Insight into examining regulations and markets prospects
Join this webinar to learn about the current regulations on the monocyte activation test (MAT) and the new kind type of MAT entering the markets.
Gene therapy trial facilitates major vision improvement
Some of the rare disease participants experienced fast and sustained improvement in their eyesight during the clinical trial, data shows.
An alternative medium to support sterility testing using the Growth Direct® Rapid Sterility System
Join this webinar to learn how a new single medium, Rapid Sterility Medium (RSM), performs as well as or better for the growth promotion of test microorganisms compared to compendial sterility test media.
First-in-class combination therapy authorised for endometriosis
The three-in-one oral daily tablet provides an additional treatment option to help women in the UK manage their endometriosis-associated pain.
Advancing NOX inhibitors for treating fibrotic diseases and cancer
This article explores the benefit of NOX inhibitors for fibrotic diseases and cancers and highlights the potential of Calliditas’ setanaxib.
New webinar: Simplify your move from a vial to a prefilled syringe
Join this webinar to learn how a new single medium, Rapid Sterility Medium (RSM), performs as well as or better for the growth promotion of test microorganisms compared to compendial sterility test media.
New WHO guidance to support manufacturers to reduce AMR risk
The recommendations offered in the guidance applies across different phases of manufacturing, from APIs, through to formulation and packaging.
Improving upstream fermentation with end-to-end automation
The automated system “significantly improved process control”, resulting in greater productivity of a small-molecule drug substance.
Innovative hypertension polypill study achieves “significant” outcomes
The triple pill demonstrated “impressive” blood pressure control for the participants compared to standard of care.
Sustainable PFAS-free synthesis for pharmaceutical compounds
The novel, environmentally-friendly synthesis strategy holds potential for manufacturing scale up, according to the research.
Mpox update – August 2024
This article discusses the impact of the recent mpox emergency, highlighting the industry’s response and potential vaccine candidates.
Novartis collaboration to innovate subcutaneous drug delivery
The multi-target agreement could enhance treatment convenience by improving subcutaneous administration options for patients.
Innovative pharma-government partnership to enhance UK clinical trials
The innovative programme supports the UK government’s objectives to boost clinical trials and increase competitiveness in life sciences.
AstraZeneca investment to increase biologic capacity in Sweden
The planned expansion is set to strengthen AstraZeneca’s capability to manufacture biologic medicines for patients globally.
European Commission licenses first treatment for acanthamoeba keratitis
Following its European approval, the small molecule treatment is set to become the standard of care for patients with the ultra-rare disease.
Semi-automatic method could provide “superior” bacterial characterisation analysis
The analysis technique offers “significant” advantages over traditional colony forming unit (CFU) counts, according to the paper.
Alzheimer’s drug milestone “bittersweet” for certain patients
The first new dementia therapy to be licensed in over 20 years, has for the first time, shown efficiency in delaying cognitive decline.
Are we set for the revised EU GMP Annex 1?
This blog is a summary of the key changes of relevance to primary packaging components
Innovative mass spec method may improve oligonucleotide therapeutic analysis
The nonIP-RP-LC-MS method provides an “easy, reliable, and cost-effective” approach for bioanalysing oligonucleotide therapies.